New Horizon Health (6606.HK) - Still Has a Long Way to Go
The article analyzed the major concerns inĀ Chinaās market of early screening (difficulty in BD,Ā pricing, payment systems, etc.), which would...
478 Views
ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
868 Views
New Horizon Health IPO Trading Update: A Blockbuster IPO but Itās Time You Plan an Exit Strategy
New Horizon Health (NHH), the pioneer in Chinaās colorectal cancer screening market started trading on the Hong Stock Exchange on 18th February. T
547 Views
New Horizon Health IPO: Trading Debut
New Horizon opened 1.2x higher at HK$58.40 in the grey market and last stood at HK$79. Our DCF sensitivity analysis shows that the grey market...
471 Views
New Horizon Health (čÆŗč¾å„åŗ·) IPO Trading: Supply-Demand Imbalance
The sentiment is strong for both retail books and institutional book. There are strong demands from the institution side and the supply is scarce....
410 Views